Neuroprotective agents for the treatment of acute ischemic stroke (Q35036473)

5 August 2017

1 reference

title

Neuroprotective agents for the treatment of acute ischemic stroke (English)

1 reference

5 August 2017

1

Bruce Ovbiagele

1 reference

5 August 2017

3

Sidney Starkman

1 reference

5 August 2017

2

Chelsea S Kidwell

1 reference

5 August 2017

4

Jeffrey L Saver

1 reference

5 August 2017

1 January 2003

1 reference

Current Neurology and Neuroscience Reports

5 August 2017

1 reference

5 August 2017

3

1 reference

5 August 2017

9-20

1 reference

5 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-003-0031-z

5 August 2017

0 references

cites work

Calcium in ischemic cell death

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0031-Z

Trends in acute ischemic stroke trials through the 20th century

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0031-Z

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0031-Z

Have randomized controlled trials of neuroprotective drugs been underpowered? An illustration of three statistical principles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0031-Z

Which targets are relevant for therapy of acute ischemic stroke?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0031-Z

Recommendations for clinical trial evaluation of acute stroke therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0031-Z

Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0031-Z

Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0031-Z

Cerestat and other NMDA antagonists in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0031-Z

Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0031-Z

Design of NAALADase inhibitors: a novel neuroprotective strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0031-Z

Effect of intravenous nimodipine on blood pressure and outcome after acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0031-Z

Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0031-Z

Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0031-Z

The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator-treated stroke (CLASS-T): final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-003-0031-Z

Neuroprotective effect of delayed moderate hypothermia after focal cerebral ischemia: an MRI study

21 January 2018

1 reference

12 December 2020

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

12 December 2020

Reduction of central nervous system reperfusion injury in rabbits using doxycycline treatment

1 reference

12 December 2020

Why do neuroprotective drugs work in animals but not humans?

1 reference

12 December 2020

Diazepam to improve acute stroke outcome: results of the early GABA-Ergic activation study in stroke trial. a randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Tirilazad for acute ischaemic stroke

1 reference

12 December 2020

Why do all drugs work in animals but none in stroke patients? 2. Neuroprotective therapy

1 reference

12 December 2020

Role of a synthetic pyrimidine compound, MS-818, in reduction of infarct size and amelioration of sensorimotor dysfunction following permanent focal cerebral ischemia in rats

1 reference

12 December 2020

Calcium antagonists for ischemic stroke: a systematic review

1 reference

12 December 2020

Neuroprotective effect of treatment with human albumin in permanent focal cerebral ischemia: histopathology and cortical perfusion studies

1 reference

12 December 2020

NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death.

1 reference

12 December 2020

Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results

1 reference

12 December 2020

Mechanisms of action of neuroprotectants in stroke

1 reference

12 December 2020

Experimental study of pharmacological hypothermia: enhanced neuroprotective effect of a novel 5-HT 1 A agonist SUN N4057 by the pharmacological hypothermia

1 reference

12 December 2020

Endovascular cooling for moderate hypothermia in patients with acute stroke: first results of a novel approach

1 reference

12 December 2020

Phase II clinical trial of sipatrigine (619C89) by continuous infusion in acute stroke

1 reference

12 December 2020

Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) trial

1 reference

12 December 2020

Prevention of in vivo excitotoxicity by a family of trialkylglycines, a novel class of neuroprotectants.

1 reference

12 December 2020

Diazepam treatment to increase the cerebral GABAergic activity in acute stroke: a feasibility study in 104 patients.

1 reference

12 December 2020

Neuroprotection in acute ischaemic stroke. Current status and future potential

1 reference

12 December 2020

Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?

1 reference

12 December 2020

Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial

1 reference

12 December 2020

Potential of anticytokine therapies in central nervous system ischaemia

1 reference

12 December 2020

Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms

1 reference

12 December 2020

Very Early Nimodipine Use in Stroke (VENUS): a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Neuroprotection and the ischemic cascade

1 reference

12 December 2020

Feasibility and safety of inducing modest hypothermia in awake patients with acute stroke through surface cooling: A case-control study: the Copenhagen Stroke Study

1 reference

12 December 2020

Piracetam for acute ischaemic stroke.

1 reference

12 December 2020

Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzole

1 reference

12 December 2020

Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?

1 reference

12 December 2020

Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial

1 reference

12 December 2020

Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group

1 reference

12 December 2020

Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia

1 reference

12 December 2020

Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest

1 reference

12 December 2020

The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke

1 reference

12 December 2020

omega-agatoxin IVA-sensitive Ca(2+) channel blocker, alpha-eudesmol, protects against brain injury after focal ischemia in rats

1 reference

12 December 2020

Cervene (Nalmefene) in acute ischemic stroke : final results of a phase III efficacy study. The Cervene Stroke Study Investigators

1 reference

12 December 2020

Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury

1 reference

12 December 2020

Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial

1 reference

12 December 2020

Effects of Intracellular Calcium Reduction by Dantrolene on Prevention/Treatment of Ischemic Stroke

1 reference

12 December 2020

Neuroprotection by the inhibition of apoptosis

1 reference

12 December 2020

Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness

1 reference

12 December 2020

Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators

1 reference

12 December 2020

Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620.

1 reference

12 December 2020

10.1007/S11910-003-0031-Z

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12507405